Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Northwestern University
PETHEMA Foundation
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute